Patents Represented by Attorney, Agent or Law Firm Incyte Genomics
-
Patent number: 6448041Abstract: The invention provides a cDNA which encodes a colon cancer marker. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of colon disorders, particularly colon cancer and polyps. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.Type: GrantFiled: December 18, 2000Date of Patent: September 10, 2002Assignee: Incyte Genomics, Inc.Inventors: Amy K. Wolven, Randi E. Krasnow, Bridget A. Warren, Mariah R. Baughn
-
Patent number: 6444430Abstract: The invention provides cDNA which encode Ndr2-related proteins. It also provides for the use of the cDNAs, fragments, complements, and variants thereof and of the encoded proteins, portions thereof and antibodies thereto for diagnosis and treatment of cancer, particularly cancers of the intestine, breast, uterus, liver, brain, and kidney. The invention additionally provides expression vectors and host cells for the production of the proteins and a transgenic model system.Type: GrantFiled: March 19, 2001Date of Patent: September 3, 2002Assignee: Incyte Genomics, Inc.Inventors: Susan G. Stuart, Janice Au-Young, Jennifer L. Hillman, Purvi Shah, Henry Yue
-
Patent number: 6436637Abstract: The invention provides a human protein phosphatase (PROPHO) and polynucleotides which identify and encode PROPHO. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of PROPHO.Type: GrantFiled: December 7, 1998Date of Patent: August 20, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Surya K. Goli, Preeti Lal, Neil C. Corley, Hong Zhang
-
Patent number: 6436683Abstract: The invention provides a human nucleic acid methylases (HNAM) and polynucleotides which identify and encode HNAM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HNAM.Type: GrantFiled: May 18, 2000Date of Patent: August 20, 2002Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley, Karl J. Guegler, Henry Yue
-
Patent number: 6432915Abstract: The present invention provides a human mitochondrial chaperone protein (Hmt-GrpE) and polynucleotides which identify and encode Hmt-GrpE. The invention also provides expression vectors and host cells and a method for producing Hmt-GrpE. The invention also provides for antibodies or antagonists specifically binding Hmt-GrpE, and their use in the prevention and treatment of cancer. The invention also provides diagnostic assays. The invention also provides for the use of Hmt-GrpE in identifying antifungal and antiprotozoal therapeutics.Type: GrantFiled: October 12, 1999Date of Patent: August 13, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Surya K. Goli
-
Patent number: 6432690Abstract: The invention provides human aspartic proteases (NHAP) and polynucleotides which identify and encode NHAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of NHAP.Type: GrantFiled: November 2, 2000Date of Patent: August 13, 2002Assignee: Incyte Genomics, Inc.Inventors: Hong Xu, Sandra A. Bruno, Laura A. Elsenboss, Michael Fogliano, Victoria L. Cohan, Olga Bandman
-
Patent number: 6432687Abstract: The invention provides a human delayed rectifier potassium channel subunit (DRPCS) and polynucleotides which identify and encode DRPCS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of DRPCS.Type: GrantFiled: December 22, 1999Date of Patent: August 13, 2002Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Chandra Patterson, Neil C. Corley
-
Patent number: 6428949Abstract: The present invention provides a novel human phosphatase inhibitor protein (HPIP) and polynucleotides which identify and encode HPIP. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HPIP and a method for producing HPIP. The invention also provides for agonists, antibodies, or antagonists specifically binding HPIP, and their use, in the prevention and treatment of diseases associated with expression of HPIP. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HPIP for the treatment of diseases associated with the expression of HPIP. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HPIP.Type: GrantFiled: March 4, 1999Date of Patent: August 6, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Surya K. Goli
-
Patent number: 6426186Abstract: The invention provides polynucleotides and polypeptides that are co-expressed with genes known to be involved in bone remodeling and osteoporosis. The invention also provides expression vectors, host cells, and methods for making a polypeptide, for screening or purifying ligands, and for diagnosing disorders associated with bone remodeling or osteoporosis.Type: GrantFiled: January 18, 2000Date of Patent: July 30, 2002Assignee: Incyte Genomics, IncInventors: Karen A. Jones, Wayne Volkmuth, Michael G. Walker
-
Patent number: 6416755Abstract: The invention provides a human beta-alanine-pyruvate aminotransferase (HAPA) and polynucleotides which identify and encode HAPA. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HAPA.Type: GrantFiled: June 13, 2000Date of Patent: July 9, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Preeti Lal, Neil C. Corley
-
Patent number: 6417329Abstract: The present invention provides a human growth factor receptor binding protein (GRBP) and polynucleotides which encode GRBP. The invention also provides expression vectors, host cells, agonists, antisense molecules, antibodies, or antagonists. The invention also provides methods for producing GRBP and for treating disorders associated with expression of GRBP.Type: GrantFiled: November 20, 1998Date of Patent: July 9, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Anthony P. Diegidio
-
Patent number: 6416991Abstract: The invention provides human cyclic nucleotide phosphodiesterases (HSPDE10A) and polynucleotides which identify and encode HSPDE10A. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists and methods for diagnosing or treating disorders associated with expression of HSPDE10A.Type: GrantFiled: June 14, 2000Date of Patent: July 9, 2002Assignee: Incyte Genomics, Inc.Inventors: Stephen C. Phillips, Jerry Lanfear, Lindsay Fawcett, Olga Bandman, Ian Harrow
-
Patent number: 6410267Abstract: The invention provides human GTPase-associated proteins (GPAP) and polynucleotides which identify and encode GPAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of GPAP.Type: GrantFiled: June 8, 2000Date of Patent: June 25, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson
-
Patent number: 6403778Abstract: The present invention relates to a composition comprising a plurality of polynucleotide targets. The composition can be used as hybridizable array elements in a microarray. The present invention also relates to methods for screening compounds and therapeutic treatments for toxicological responses.Type: GrantFiled: August 28, 1998Date of Patent: June 11, 2002Assignee: Incyte Genomics, Inc.Inventors: Mary Jane Cunningham, Gary B. Zweiger, Scott R. Panzer, Jeffrey J. Seilhamer
-
Patent number: 6399345Abstract: The present invention provides four NADH dehydrogenase subunits (designated individually as NDS-1, NDS-2, NDS-3, and NDS-4 and collectively as NDS) and polynucleotides which identify and encode NDS. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NDS and a method for producing NDS. The invention also provides for use of NDS and agonists, antibodies, or antagonists specifically binding NDS, in the prevention and treatment of diseases associated with expression of NDS. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding NDS for the treatment of diseases associated with the expression of NDS. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding NDS.Type: GrantFiled: September 10, 1998Date of Patent: June 4, 2002Assignee: Incyte Genomics, Inc.Inventors: Olga Bandman, Surya K. Goli, Jennifer L. Hillman
-
Patent number: 6399301Abstract: The invention provides a human phospholipase A2 protein PHPLA2 and polynucleotides which identify and encode PHPLA2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of PHPLA2.Type: GrantFiled: January 21, 2000Date of Patent: June 4, 2002Assignee: Incyte Genomics, Inc.Inventors: Phillip R. Hawkins, Olga Bandman, Karl J. Guegler, Purvi Shah, Neil C. Gorley
-
Patent number: 6395468Abstract: The present invention provides a human phosphatidylinositol synthase (PISH) and polynucleotides which identify and encode PISH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding PISH and a method for producing PISH. The invention also provides for agonists, antibodies, or antagonists specifically binding PISH, and their use, in the prevention and treatment of diseases associated with expression of PISH. The invention also provides for the use of PISH in screening for antiprotozoal and antifungal therapeutics. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding PISH for the treatment of diseases associated with the expression of PISH. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding PISH.Type: GrantFiled: December 18, 1998Date of Patent: May 28, 2002Assignee: Inyte Genomics, Inc.Inventors: Olga Bandman, Surya K. Goli
-
Patent number: 6391580Abstract: The invention provides seven human Ras proteins (RASP) and polynucleotides which identify and encode RASP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of RASP.Type: GrantFiled: May 8, 1998Date of Patent: May 21, 2002Assignee: Incyte Genomics, Inc.Inventors: Jennifer L. Hillman, Y. Tom Tang, Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson, Sajeev Batra, Mariah R. Baughn
-
Patent number: 6387613Abstract: The invention provides a human short-chain dehydrogenase (HSCD) and polynucleotides which identify and encode HSCD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HSCD.Type: GrantFiled: February 11, 1999Date of Patent: May 14, 2002Assignee: Incyte Genomics, Inc.Inventors: Preeti Lal, Neil C. Corley
-
Patent number: 6379904Abstract: The invention provides a human PINCH protein homolog (PINCH-PH) and polynucleotides which identify and encode PINCH-PH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of PINCH-PH.Type: GrantFiled: March 20, 2000Date of Patent: April 30, 2002Assignee: Incyte Genomics, Inc.Inventors: Preeti Lal, Karl J. Guegler, Neil C. Corley